Medicilon completed full sets of non-clinical research projects for new drugs such as ophthalmic solutions or intravitreal injections
Medicilon has been conducting comprehensive non-clinical research for ophthalmic drugs since 2013, with extensive experience from active pharmaceutical ingredients and formulations to pharmacodynamics, pharmacokinetics, and safety assessments, and has contributed to the approval of multiple ophthalmic drugs.
Medicilon large animal models such as non-human primates, dogs, rabbits, and miniature pigs have shown unique advantages and value in key areas of drug development
With the advent of the era of precision medicine and the deepening understanding of disease mechanisms, large animal models such as non-human primates, dogs, rabbits, and miniature pigs have shown unique advantages and value in key areas of drug development.
Targeting IL-23, Medicilon assists the development of a variety of new drugs for Psoriasis
With people’s in-depth understanding of the inflammatory pathways of psoriasis, biologics continue to develop. From tumor necrosis factor alpha (TNF-α), to IL-17 inhibitors, and then to IL-23 inhibitors, biologics have brought new light to the treatment of psoriasis again. In recent years, the exploration of IL-23 by new drug developers has never stopped. Medicilon Assists IL-23 Monoclonal…
Medicilon neural system disease models help our clients advance novel drug development
Medicilon Pharmacodynamics Department can deliver multiple nervous system models based on anti-depressants, anti-Alzheimer's drugs, sedative-hypnotic and anti-anxiety drugs, analgesics, anti-convulsant, anti-Parkinson's drugs, and anti-schizophrenia drugs.
Medicilon delivers fast turnaround time to meet your FDA submission deadline for SEND Format Conversion
Medicilon's preclinical pharmacology and toxicology research team is equipped with a professional send format conversion team and has established a send data conversion platform that is fully developed in terms of software, technology, specification and quality, to realize accurate data conversion and provide a good environment for electronic data submission.
Medicilon delivers Green Chemistry Solutions for drug development
Environmental pollution and energy waste causes the destruction of ecosystems, extinction of species and global warming, leading to serious and long-lasting global challenges. To mitigate these challenges, green chemistry approaches are being developed and introduced into chemical and pharmaceutical industries to deliver improved environmental sustainability into drug development and…